ATE241697T1 - Pseudo-cyclische oligonukleobasen - Google Patents

Pseudo-cyclische oligonukleobasen

Info

Publication number
ATE241697T1
ATE241697T1 AT00920072T AT00920072T ATE241697T1 AT E241697 T1 ATE241697 T1 AT E241697T1 AT 00920072 T AT00920072 T AT 00920072T AT 00920072 T AT00920072 T AT 00920072T AT E241697 T1 ATE241697 T1 AT E241697T1
Authority
AT
Austria
Prior art keywords
pcos
segment
oligonucleotides
pseudo
cyclic
Prior art date
Application number
AT00920072T
Other languages
English (en)
Inventor
Sudhir Agrawal
Ekambar R Kandimalla
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Application granted granted Critical
Publication of ATE241697T1 publication Critical patent/ATE241697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Holo Graphy (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00920072T 1999-03-31 2000-03-31 Pseudo-cyclische oligonukleobasen ATE241697T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12713899P 1999-03-31 1999-03-31
US17464200P 2000-01-05 2000-01-05
PCT/US2000/008826 WO2000058330A2 (en) 1999-03-31 2000-03-31 Pseudo-cyclic oligonucleobases

Publications (1)

Publication Number Publication Date
ATE241697T1 true ATE241697T1 (de) 2003-06-15

Family

ID=26825372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00920072T ATE241697T1 (de) 1999-03-31 2000-03-31 Pseudo-cyclische oligonukleobasen

Country Status (9)

Country Link
EP (1) EP1086216B1 (de)
AT (1) ATE241697T1 (de)
AU (1) AU770615B2 (de)
CA (1) CA2334707A1 (de)
DE (1) DE60002967T2 (de)
DK (1) DK1086216T3 (de)
ES (1) ES2197868T3 (de)
PT (1) PT1086216E (de)
WO (1) WO2000058330A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099959A1 (en) * 1995-04-12 2003-05-29 Kandimalla Ekambar R. Cooperative oligonucleotides
EP2470656B1 (de) * 2009-08-27 2015-05-06 Idera Pharmaceuticals, Inc. Zusammensetzung zur genexpressionshemmung und ihre anwendungen
WO2012102616A1 (en) * 2011-01-28 2012-08-02 Flexgen B.V. Heterodirectional polynucleotides
WO2023049275A2 (en) * 2021-09-23 2023-03-30 Arnay Sciences, Llc Cyclic structured oligonucleotides as therapeutic agents
WO2024197139A2 (en) * 2023-03-22 2024-09-26 Arnay Sciences, Llc Delivery of rna therapeutics using circular prodrug nucleic acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399676A (en) * 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
PL172710B1 (pl) * 1992-07-02 1997-11-28 Hybridon Inc Samostabilizujacy sie oligonukleotyd PL PL
WO1996035706A1 (en) * 1995-05-11 1996-11-14 Hybridon, Inc. Pyrimidine targeting hairpin triplex-forming oligonucleotides
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon

Also Published As

Publication number Publication date
DK1086216T3 (da) 2003-08-18
AU770615B2 (en) 2004-02-26
WO2000058330A3 (en) 2001-01-25
CA2334707A1 (en) 2000-10-05
WO2000058330A2 (en) 2000-10-05
DE60002967D1 (de) 2003-07-03
EP1086216B1 (de) 2003-05-28
PT1086216E (pt) 2003-09-30
EP1086216A2 (de) 2001-03-28
DE60002967T2 (de) 2004-05-19
ES2197868T3 (es) 2004-01-16
AU4066600A (en) 2000-10-16

Similar Documents

Publication Publication Date Title
Nielsen Peptide nucleic acid. A molecule with two identities
Elayadi et al. Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase
KR101201664B1 (ko) 신규한 형태의 간섭 ｒｎａ 분자
RU2006126643A (ru) Олигомерные соединения для модуляции bcl-2
CA2526831A1 (en) Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
ATE460481T1 (de) Verfahren zur hemmung der expression eines zielgens und medikament zur therapie einer tumorerkrankung
DE69719220D1 (de) Neue nucleotidanaloga
ATE484586T1 (de) Synthetische doppelsträngige oligonucleotide zur gezielten hemmung der genexpression
JP2023519140A5 (de)
JP2005517436A5 (de)
Moccia et al. Insights on chiral, backbone modified peptide nucleic acids: properties and biological activity
Rapozzi et al. Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene
WO2004078941A3 (en) Modulation of gene expression using dna-rna hybrids
DK1086216T3 (da) Pseudo-cykliske oligonukleobaser
Kupryushkin et al. Efficient functionalization of oligonucleotides by new achiral nonnucleosidic monomers
Lee et al. Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation
Thai et al. Tetrahedral DNAzymes for enhanced intracellular gene-silencing activity
HRP20100666T1 (hr) ANTI MIOZINSKA Va siRNA I DEPIGMENTACIJA KOŽE
Pradhan et al. Induced circular dichroism of benzo [a] pyrene-7, 8-dihydrodiol 9, 10-epoxide stereoisomers covalently bound to deoxyribooligonucleotides used to probe equilibrium distribution between groove binding and intercalative adduct conformations
Opalinska et al. Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules
Reddy et al. Solid-phase synthesis of positively charged deoxynucleic guanidine (DNG) tethering a Hoechst 33258 analogue: triplex and duplex stabilization by simultaneous minor groove binding
ATE321857T1 (de) Pca3 mrna in gutartigen und bösartigen prostatageweben
Hu et al. Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy) phenyl] pyrrolocytosine
KR20120029002A (ko) 신규한 형태의 간섭 ｒｎａ 분자
Agrawal Considerations for creating the next generation of RNA therapeutics: oligonucleotide chemistry and innate immune responses to nucleic acids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1086216

Country of ref document: EP

REN Ceased due to non-payment of the annual fee